What's New
FTD in the News
Vesper Bio Announces Successful Completion of Phase 1 Study for Potentially Disease-Modifying Treatment for FTD-GRN
Biotechnology company Vesper Bio announced in early September that the phase 1 clinical trial for its potentially…
AC Immune and Life Molecular Imaging Announce FDA Fast Track Designation for Tau PET Tracer
Swiss biopharmaceutical company AC Immune announced in late August that its partner, German biopharmaceutical company Life Molecular…
Emma Heming Willis Shares Her FTD Experience and Advocacy Work in “Town & Country” Magazine
Emma Heming Willis spoke with journalist Katie Couric about her journey as an FTD care partner, as…
Young Woman Tells Her Family’s FTD Story on Philadelphia News Segment
FTD care partner Hannah Clarke was interviewed on October 15 for a segment on Good Day Philadelphia…
Study Finds Suicidal Thoughts Likelier in People with Dementia, Calls for Better Supports
A study conducted by researchers at University College London (UCL) published in the journal Ageing Research Reviews…
AFTD Ambassador Shares Her Family’s FTD Story with Massachusetts Newspaper
Dawn O’Gara, an ATD Ambassador, spoke about her beloved father’s FTD diagnosis and how it spurred her…
Astellas and AviadoBio Announce Exclusive License Agreement for FTD-GRN Gene Therapy
Astellas Pharma and AviadoBio have announced an exclusive license agreement for AVB-101, an experimental gene therapy for…
Study Finds That FTD and ALS Have Similar Cellular and Molecular Characteristics
A study by MIT and Mayo Clinic researchers published in the Cell journal finds that FTD and…
The Power of Advocacy
AFTD would like to highlight the power of advocacy in contributing to the greater awareness of FTD….
Psilera Announces Positive Preclinical Data for FTD Intervention Candidate
Biotechnology company Psilera announced positive preclinical data for its FTD drug candidate, moving it another step towards…